ArticleFrontiers in oncology2025

Identification of novel molecular subtypes and construction of a prognostic signature via multi-omics analysis and machine learning in lung adenocarcinoma.

Ke Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.